According to a report by Malaysian media Star on November 7th, the Malaysian Medical Association (MMA) has urged the government to immediately classify nicotine under the Poison Act for regulation.
The association, in a press release issued on Monday, November 6th, stated that liquid and gel nicotine should be immediately reclassified under the controlled substances list of the 1952 Poison Law.
In June 2023, the head of the MMA reported a total of 17 cases related to e-cigarette use and associated lung injuries (EVALI) for that month alone.
He also stated that the data obtained from the 2022 National Health and Morbidity Survey (NHMS) reveals that the usage rate of e-cigarettes among teenagers aged 13 to 17 has increased from 9.8% in 2017 to 14.9% in 2022. The proportion of female users has also significantly risen, from 2.8% in 2017 to 6.2% in 2022.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
